Miravalle A - Search Results

1

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.

Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Berger JR, et al. Among authors: miravalle a. Ann Neurol. 2010 Sep;68(3):409-11. doi: 10.1002/ana.22083. Ann Neurol. 2010. PMID: 20818795 No abstract available.

2

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy.

Miravalle A, Jensen R, Kinkel RP. Miravalle A, et al. Arch Neurol. 2011 Feb;68(2):186-91. doi: 10.1001/archneurol.2010.257. Epub 2010 Oct 11. Arch Neurol. 2011. PMID: 20937940

3

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.

Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Kleinschmidt-DeMasters BK, et al. Among authors: miravalle a. J Neuropathol Exp Neurol. 2012 Jul;71(7):604-17. doi: 10.1097/NEN.0b013e31825caf2c. J Neuropathol Exp Neurol. 2012. PMID: 22710964 Review.

4

Therapeutic options in multiple sclerosis: five new things.

Miravalle A, Corboy JR. Miravalle A, et al. Neurology. 2010 Nov 2;75(18 Suppl 1):S22-7. doi: 10.1212/WNL.0b013e3181fb3676. Neurology. 2010. PMID: 21041767 Review. No abstract available.

5

Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.

Rempe T, Wang Q, Wu Q, Ballur Narayana Reddy V, Newcomer Z, Miravalle A, Mao-Draayer Y. Rempe T, et al. Among authors: miravalle a. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 20;7(3):e709. doi: 10.1212/NXI.0000000000000709. Print 2020 May 4. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32198230 Free PMC article. No abstract available.

6

Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.

Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Alvarez E, et al. Among authors: miravalle a. Mult Scler Relat Disord. 2021 Oct;55:103170. doi: 10.1016/j.msard.2021.103170. Epub 2021 Jul 24. Mult Scler Relat Disord. 2021. PMID: 34364034

7

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis.

Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S. Prosperini L, et al. Among authors: miravalle aa. Ther Adv Neurol Disord. 2019 Mar 29;12:1756286419837809. doi: 10.1177/1756286419837809. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30956686 Free PMC article.

8

Remyelination Therapy in Multiple Sclerosis.

Harlow DE, Honce JM, Miravalle AA. Harlow DE, et al. Among authors: miravalle aa. Front Neurol. 2015 Dec 10;6:257. doi: 10.3389/fneur.2015.00257. eCollection 2015. Front Neurol. 2015. PMID: 26696956 Free PMC article. Review.

9

Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates.

Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T, Corboy J, Miravalle A, Schreiner T, Porter V, Nair K. Campbell JD, et al. Among authors: miravalle a. Mult Scler Relat Disord. 2014 Mar;3(2):227-36. doi: 10.1016/j.msard.2013.09.004. Epub 2013 Nov 2. Mult Scler Relat Disord. 2014. PMID: 25878010

10

Encephalitis complicating smallpox vaccination.

Miravalle A, Roos KL. Miravalle A, et al. Arch Neurol. 2003 Jul;60(7):925-8. doi: 10.1001/archneur.60.7.925. Arch Neurol. 2003. PMID: 12873847 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters